Stock Code: 002923 Stock Abbreviation: Rundu Shares
Zhuhai Rundu Pharmaceutical Co., Ltd.
Simplified Report on Change of Equity
Name of Listed Company: Zhuhai Rundu Pharmaceutical Co., Ltd.
Place of Listing: Shenzhen Stock Exchange
Stock Abbreviation: Rundu Shares
Stock Code: 002923
Information Disclosure Obligor 1: Li Xi
Domicile: Guangzhou, Guangdong Province
Correspondence Address: No. 6, Airport North Road, Sanzao Town, Jinwan District, Zhuhai City, Guangdong Province
Information Disclosure Obligor 2 (Person Acting in Concert): Chen Xinmin
Domicile: Zhuhai, Guangdong Province
Nature of Change in Equity: Reduction of shares (reaching a 5% integer multiple)
Date of Signing: July 06, 2026
Declaration of Information Disclosure Obligors
-
This report is prepared by the information disclosure obligors in accordance with the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, the Administrative Measures for the Takeover of Listed Companies, the Standards for the Contents and Formats of Information Disclosure by Companies Offering Securities to the Public No. 15—Report on Change of Equity, and other relevant laws, regulations, and departmental rules.
-
The information disclosure obligors have obtained the necessary authorization and approval for signing this report.
-
In accordance with the Securities Law of the People's Republic of China, the Administrative Measures for the Takeover of Listed Companies, and the Standards for the Contents and Formats of Information Disclosure by Companies Offering Securities to the Public No. 15—Report on Change of Equity, this report has fully disclosed the changes in the equity held by the information disclosure obligors in Zhuhai Rundu Pharmaceutical Co., Ltd. (hereinafter referred to as "Rundu Shares" or the "Listed Company"). As of the date of signing this report, except for the information disclosed in this report, the information disclosure obligors have not increased or decreased their equity in Rundu Shares through any other means.
-
This change in equity is conducted based on the information contained in this report. Except for the information disclosure obligors, no other person has been entrusted or authorized to provide information not contained in this report or to make any interpretation or explanation of this report.
-
The information disclosure obligors promise that this report does not contain any false records, misleading statements, or major omissions, and assume legal responsibility for its authenticity, accuracy, and completeness.
Table of Contents
Declaration of Information Disclosure Obligors 2
Definitions 4
Section I Introduction to Information Disclosure Obligors 5
Section II Purpose of Equity Change and Shareholding Plan 7
Section III Method of Equity Change 8
Section IV Transactions of Listed Company Shares in the Previous 6 Months 11
Section V Other Major Matters 12
Section VI Documents Available for Inspection 13
Declaration of Information Disclosure Obligors 14
Appendix 15
Definitions
In this report, unless the context otherwise requires, the following abbreviations have the following meanings:
| Abbreviation | Meaning |
|---|---|
| This Report, Report | Simplified Report on Change of Equity of Zhuhai Rundu Pharmaceutical Co., Ltd. |
| Listed Company, Company, Rundu Shares | Zhuhai Rundu Pharmaceutical Co., Ltd. |
| Information Disclosure Obligors | Li Xi, Chen Xinmin |
| CSRC | China Securities Regulatory Commission |
| SZSE, Exchange, Stock Exchange | Shenzhen Stock Exchange |
| Securities Law | Securities Law of the People's Republic of China |
| Administrative Measures | Administrative Measures for the Takeover of Listed Companies |
| Standards No. 15 | Standards for the Contents and Formats of Information Disclosure by Companies Offering Securities to the Public No. 15—Report on Change of Equity |
| Working Day | Business day of commercial banks in the People's Republic of China (excluding statutory holidays) |
| Yuan, Ten Thousand Yuan | RMB Yuan, RMB Ten Thousand Yuan |